2024 Q2 Form 10-K Financial Statement

#000149315224012608 Filed on April 02, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $7.017M $15.53M $75.30M
YoY Change -65.85% -3.26% 136.63%
Cost Of Revenue $5.239M $14.13M $66.81M
YoY Change -70.92% -9.54% 125.49%
Gross Profit $1.778M $1.396M $8.492M
YoY Change -29.73% 224.69% 287.09%
Gross Profit Margin 25.34% 8.99% 11.28%
Selling, General & Admin $3.461M $2.257M $16.34M
YoY Change -30.79% -62.38% -0.4%
% of Gross Profit 194.69% 161.68% 192.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $37.99K $1.141M $3.045M
YoY Change -23.24% 70.23% 1026.25%
% of Gross Profit 2.14% 81.69% 35.85%
Operating Expenses $3.461M $2.257M $16.34M
YoY Change -34.62% -62.38% -0.4%
Operating Profit -$1.683M -$861.2K -$7.843M
YoY Change -39.1% -84.54% -49.42%
Interest Expense -$1.324M -$3.209M -$58.48M
YoY Change -1391.57% 176.63% -84398.97%
% of Operating Profit
Other Income/Expense, Net $6.132M $41.18K $139.2K
YoY Change -200.71% 37.27% -100.43%
Pretax Income $4.449M -$6.163M -$68.32M
YoY Change -150.25% -22.96% 43.47%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $4.449M -$6.163M -$68.32M
YoY Change -150.25% -22.96% 44.57%
Net Earnings / Revenue 63.4% -39.69% -90.73%
Basic Earnings Per Share $0.51 -$23.63
Diluted Earnings Per Share $0.43 -$1.43 -$23.63
COMMON SHARES
Basic Shares Outstanding 8.537M shares 4.336M shares
Diluted Shares Outstanding 10.37M shares 2.891M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $673.8K $5.253M $5.253M
YoY Change -85.45% -7.36% -7.36%
Cash & Equivalents $400.0K $5.248M $5.248M
Short-Term Investments $310.7K $4.990K $4.990K
Other Short-Term Assets $934.8K $802.9K $802.9K
YoY Change 10.29% -44.09% -69.7%
Inventory $4.780M $6.080M $6.080M
Prepaid Expenses
Receivables $2.099M $1.874M $1.874M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.176M $14.01M $14.01M
YoY Change -52.98% -0.52% -0.5%
LONG-TERM ASSETS
Property, Plant & Equipment $662.9K $744.6K $744.6K
YoY Change -22.6% -43.64% -46.43%
Goodwill $22.32M $22.32M
YoY Change 0.0% 0.0%
Intangibles $16.11M
YoY Change -13.3%
Long-Term Investments $2.224M $2.224M $2.224M
YoY Change 0.19% 0.19% 0.19%
Other Assets
YoY Change
Total Long-Term Assets $40.19M $41.40M $41.40M
YoY Change -6.6% -7.0% -7.0%
TOTAL ASSETS
Total Short-Term Assets $8.176M $14.01M $14.01M
Total Long-Term Assets $40.19M $41.40M $41.40M
Total Assets $48.37M $55.41M $55.41M
YoY Change -19.95% -5.44% -5.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.032M $2.517M $2.517M
YoY Change -14.64% 15.79% 16.01%
Accrued Expenses $6.673M $7.187M $7.187M
YoY Change 25.44% 178.55% 178.55%
Deferred Revenue
YoY Change
Short-Term Debt $7.200M $6.625M $6.625M
YoY Change 78.66% 258.11% 258.11%
Long-Term Debt Due $11.50M $16.14M $16.14M
YoY Change 492.78%
Total Short-Term Liabilities $25.81M $39.44M $39.44M
YoY Change 23.31% 183.38% 183.36%
LONG-TERM LIABILITIES
Long-Term Debt $9.049M $14.13M $14.13M
YoY Change -66.3% -56.72% -56.72%
Other Long-Term Liabilities $0.00 $6.100M $6.100M
YoY Change -100.0% -0.49% -0.49%
Total Long-Term Liabilities $9.049M $20.23M $20.23M
YoY Change -72.54% -47.84% -47.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.81M $39.44M $39.44M
Total Long-Term Liabilities $9.049M $20.23M $20.23M
Total Liabilities $34.94M $59.34M $59.34M
YoY Change -35.26% 12.42% 13.1%
SHAREHOLDERS EQUITY
Retained Earnings -$106.9M -$113.3M
YoY Change 3.11% 151.96%
Common Stock $120.2M $108.6M
YoY Change 9.43% 114.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.84M -$3.933M -$3.933M
YoY Change
Total Liabilities & Shareholders Equity $48.37M $55.41M $55.41M
YoY Change -19.95% -5.44% -5.44%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $4.449M -$6.163M -$68.32M
YoY Change -150.25% -22.96% 44.57%
Depreciation, Depletion And Amortization $37.99K $1.141M $3.045M
YoY Change -23.24% 70.23% 1026.25%
Cash From Operating Activities -$440.3K $298.9K -$6.399M
YoY Change -39.69% -119.29% -61.73%
INVESTING ACTIVITIES
Capital Expenditures $5.880K $112.3K $476.2K
YoY Change -96.33% -37.62% 83.13%
Acquisitions
YoY Change
Other Investing Activities $1.000K $181.0K
YoY Change -99.86% -75.21%
Cash From Investing Activities -$5.880K -$112.3K -$295.2K
YoY Change -96.33% -120.41% -163.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$645.2K
YoY Change -94.38%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 460.0 1.403M 6.362M
YoY Change -99.98% -2905.04% -69.59%
NET CHANGE
Cash From Operating Activities -440.3K 298.9K -6.399M
Cash From Investing Activities -5.880K -112.3K -295.2K
Cash From Financing Activities 460.0 1.403M 6.362M
Net Change In Cash -445.7K 1.589M -332.6K
YoY Change -134.55% -251.35% -107.12%
FREE CASH FLOW
Cash From Operating Activities -$440.3K $298.9K -$6.399M
Capital Expenditures $5.880K $112.3K $476.2K
Free Cash Flow -$446.2K $186.7K -$6.875M
YoY Change -49.87% -110.79% -59.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Restricted Cash
RestrictedCash
usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
usd
CY2023 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2022 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
usd
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2022 OCTO Repurchase Of Warrants From Noteholders
RepurchaseOfWarrantsFromNoteholders
usd
CY2022 OCTO Repayments Of Distributions
RepaymentsOfDistributions
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 OCTO Right Of Use Assets Noncash Supplemental
RightOfUseAssetsNoncashSupplemental
usd
CY2023 OCTO Operating Lease Liabilities Noncash Supplemental
OperatingLeaseLiabilitiesNoncashSupplemental
usd
CY2022 OCTO Convertible Shares Under Notes Payable
ConvertibleSharesUnderNotesPayable
usd
CY2023 OCTO Accrued Placement Agent Fees For Equity Placement
AccruedPlacementAgentFeesForEquityPlacement
usd
CY2023 OCTO Purchase Of Property Plant And Equipment Through Settlement Of Portion Of Loan Heldforinvestment
PurchaseOfPropertyPlantAndEquipmentThroughSettlementOfPortionOfLoanHeldforinvestment
usd
CY2023 OCTO Fair Value Of Preferred Units Of Issued In Acquisition Reflected As Additional Paid In Capital
FairValueOfPreferredUnitsOfIssuedInAcquisitionReflectedAsAdditionalPaidInCapital
usd
CY2023 OCTO Convertible Shares Under Notes Payable Related Party
ConvertibleSharesUnderNotesPayableRelatedParty
usd
CY2023 OCTO Accrual For Contingent Consideration For Acquisition
AccrualForContingentConsiderationForAcquisition
usd
CY2023 us-gaap Stock Issued1
StockIssued1
usd
CY2023Q4 OCTO Prepaid Software Deposit
PrepaidSoftwareDeposit
usd
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
usd
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
usd
CY2023Q4 OCTO Customer Deposits Liability Current
CustomerDepositsLiabilityCurrent
usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
usd
CY2023Q4 OCTO Deferred Tax Assets Leases
DeferredTaxAssetsLeases
usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q4 OCTO Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023 OCTO Net Deferred Tax Expense After Valuation Allowance
NetDeferredTaxExpenseAfterValuationAllowance
usd
CY2022 OCTO Net Deferred Tax Expense After Valuation Allowance
NetDeferredTaxExpenseAfterValuationAllowance
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
4093446 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8537310 shares
CY2023 dei Auditor Firm
AuditorFirmId
536
CY2023 dei Auditor Name
AuditorName
Morison Cogen LLP
CY2023 dei Auditor Location
AuditorLocation
Blue Bell, Pennsylvania
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5247836 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5580431 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
1000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1873950 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1263552 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
6079907 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
4502003 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
807908 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1736145 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
14009601 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
14082131 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
744559 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1321042 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68600 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16108443 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18579986 usd
CY2023Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2022Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2023Q4 OCTO Loans Held For Investment
LoansHeldForInvestment
2224252 usd
CY2022Q4 OCTO Loans Held For Investment
LoansHeldForInvestment
2224252 usd
CY2023Q4 us-gaap Assets
Assets
55411443 usd
CY2022Q4 us-gaap Assets
Assets
58600599 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
43950 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
277750 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
39443542 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13919202 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26564 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
82104 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
82104 usd
CY2023Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
6100000 usd
CY2022Q4 us-gaap Asset Acquisition Contingent Consideration Liability
AssetAcquisitionContingentConsiderationLiability
6100000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
59759346 usd
CY2022Q4 us-gaap Liabilities
Liabilities
52789375 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4706419 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4706419 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
633365 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
633365 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4706 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
633 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
108617178 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50617631 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113278588 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44958199 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
723303 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
467668 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3933401 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
6127733 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
-414502 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-316509 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4347903 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55411443 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58600599 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
75297484 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31820779 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
66805023 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
29626869 usd
CY2023 us-gaap Gross Profit
GrossProfit
8492461 usd
CY2022 us-gaap Gross Profit
GrossProfit
2193910 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16335651 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16401414 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
2133982 usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
1300000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
18469633 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
17701414 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-9977172 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-15507504 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-11553589 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6966606 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
46928815 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
139162 usd
CY2022 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
173572 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-58343242 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32111553 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68320414 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47619057 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-172997 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68320414 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-47446060 usd
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25 usd
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-187649 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-68320389 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-47258411 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-23.63
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-23.63
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-150.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-150.95
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
2891144 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2891144 shares
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
313072 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
313072 shares
CY2023 us-gaap Profit Loss
ProfitLoss
-68320414 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-47446060 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
255635 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
467688 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68064779 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46978372 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2023 OCTO Stock Issued During Period Value Issuance Of Common Stock To Note Holders
StockIssuedDuringPeriodValueIssuanceOfCommonStockToNoteHolders
7743333 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14800 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
51264424 usd
CY2023 OCTO Repurchase Of Warrants From Noteholder
RepurchaseOfWarrantsFromNoteholder
-660000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-854000 usd
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
495063 usd
CY2023 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
97968 usd
CY2023 OCTO Stock Issued During Period Value Foreign Currency Translation
StockIssuedDuringPeriodValueForeignCurrencyTranslation
255635 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68320414 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4347903 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2171352 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2171352 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12000000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9152 usd
CY2022 OCTO Stock Issued During Period Value Issuance Of Common Stock To Note Holders
StockIssuedDuringPeriodValueIssuanceOfCommonStockToNoteHolders
1590000 usd
CY2022 OCTO Stock Issued During Period Value Issuance Of Warrants To Noteholders And Placement Agent
StockIssuedDuringPeriodValueIssuanceOfWarrantsToNoteholdersAndPlacementAgent
29224067 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
960000 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
49455 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1504500 usd
CY2022 OCTO Stock Issued During Period Value Shares Reserved For Future Issuance Of Common Stock
StockIssuedDuringPeriodValueSharesReservedForFutureIssuanceOfCommonStock
7300000 usd
CY2022 OCTO Stock Issued During Period Value Foreign Currency Translation
StockIssuedDuringPeriodValueForeignCurrencyTranslation
467668 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-47446060 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5811224 usd
CY2023 us-gaap Profit Loss
ProfitLoss
-68320414 usd
CY2022 us-gaap Profit Loss
ProfitLoss
-47446060 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3044531 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
848933 usd
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
8109078 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
6217053 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
292748 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1300000 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
46928815 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
25318519 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
-358937 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1504500 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
608356 usd
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5897 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
610398 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
443312 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1322269 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3541152 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-928237 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5462405 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
343390 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-25775 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
4560243 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-13605160 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6399079 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16719389 usd
CY2023 OCTO Payments To Proceeds From Property And Equipment Acquisition
PaymentsToProceedsFromPropertyAndEquipmentAcquisition
117387 usd
CY2022 OCTO Payments To Proceeds From Property And Equipment Acquisition
PaymentsToProceedsFromPropertyAndEquipmentAcquisition
105703 usd
CY2023 us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
358763 usd
CY2022 us-gaap Payments To Acquire Projects
PaymentsToAcquireProjects
158594 usd
CY2022 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
732716 usd
CY2023 us-gaap Proceeds From Sale Of Intangible Assets
ProceedsFromSaleOfIntangibleAssets
181000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-295150 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
468419 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14798 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11529152 usd
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4775000 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3360000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
7000000 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-249507 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
49455 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
3028154 usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
560000 usd
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
664389 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
116300 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
27644 usd
CY2023 OCTO Repurchase Of Warrants From Noteholders
RepurchaseOfWarrantsFromNoteholders
660000 usd
CY2023 OCTO Repayments Of Distributions
RepaymentsOfDistributions
97968 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6361634 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
20920207 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-332595 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4669237 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5580431 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
911194 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5247836 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5580431 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
444781 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
203 usd
CY2022 OCTO Right Of Use Assets Noncash Supplemental
RightOfUseAssetsNoncashSupplemental
98736 usd
CY2022 OCTO Operating Lease Liabilities Noncash Supplemental
OperatingLeaseLiabilitiesNoncashSupplemental
98736 usd
CY2023 OCTO Convertible Shares Under Notes Payable
ConvertibleSharesUnderNotesPayable
7743333 usd
CY2023 OCTO Warrants Issued
WarrantsIssued
4335611 usd
CY2022 OCTO Warrants Issued
WarrantsIssued
3905458 usd
CY2023 OCTO Original Issue Discount
OriginalIssueDiscount
555000 usd
CY2022 OCTO Original Issue Discount
OriginalIssueDiscount
3333333 usd
CY2022 OCTO Accrued Placement Agent Fees For Equity Placement
AccruedPlacementAgentFeesForEquityPlacement
480000 usd
CY2022 OCTO Purchase Of Property Plant And Equipment Through Settlement Of Portion Of Loan Heldforinvestment
PurchaseOfPropertyPlantAndEquipmentThroughSettlementOfPortionOfLoanHeldforinvestment
1775748 usd
CY2022 OCTO Fair Value Of Preferred Units Of Issued In Acquisition Reflected As Additional Paid In Capital
FairValueOfPreferredUnitsOfIssuedInAcquisitionReflectedAsAdditionalPaidInCapital
7300000 usd
CY2022 OCTO Convertible Shares Under Notes Payable Related Party
ConvertibleSharesUnderNotesPayableRelatedParty
24500000 usd
CY2022 OCTO Accrual For Contingent Consideration For Acquisition
AccrualForContingentConsiderationForAcquisition
6100000 usd
CY2022 us-gaap Stock Issued1
StockIssued1
18805 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-50
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zVOaZmSb9bf7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zx9gNsq5wpY6">Use of Estimates</span>. </i>The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. The Company’s significant estimates used in these consolidated financial statements include, but are not limited to, revenue recognition and the determination of the economic useful life of depreciable property and equipment. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
67350 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
46705 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
292748 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1300000 usd
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4253074 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1837673 shares
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
31815804 usd
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zQOdhZS2Kf4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zmcME3vfqeg9">Concentration of Credit Risks</span>. </i>Financial instruments that potentially subject the Company to concentrations of credit risk are cash equivalents and accounts receivable. Cash and cash equivalents are invested in deposits with certain financial institutions and may, at times, exceed federally insured limits. The Company has not experienced any significant losses on its deposits of cash and cash equivalents. In regard to trade receivables, the Company performs ongoing evaluations of its customers’ financial condition as well as general economic conditions and, generally, requires no collateral from its customers. On December 31, 2023, amount due from one customer totaled approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20231201__20231231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zCzZcD3vh1yc" title="Concentration risk percentage">21</span>% of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98736 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-113278588 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5200000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5600000 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
500000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27500000 usd
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27500000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1941300 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1871908 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
67350 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
608356 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1873950 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1263552 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
22116 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
27922 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
6657791 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5174081 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
600000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
700000 usd
CY2023Q4 OCTO Inventories Net
InventoriesNet
6079907 usd
CY2022Q4 OCTO Inventories Net
InventoriesNet
4502003 usd
CY2023Q4 OCTO Advances For Inventory Purchases
AdvancesForInventoryPurchases
517228 usd
CY2022Q4 OCTO Advances For Inventory Purchases
AdvancesForInventoryPurchases
630967 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
91075 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
735934 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
4994 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
90578 usd
CY2022Q4 OCTO Prepaid Software Deposit
PrepaidSoftwareDeposit
242200 usd
CY2023Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
106846 usd
CY2023Q4 OCTO Other Current Assets
OtherCurrentAssets
87765 usd
CY2022Q4 OCTO Other Current Assets
OtherCurrentAssets
36466 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
807908 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1736145 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6404551 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6781752 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5659992 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5460710 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
744559 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1321042 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
199282 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
270325 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
292748 usd
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1300000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19519775 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
19158594 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3411332 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-578608 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16108443 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18579986 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2832724 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
578608 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
2314431 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
2314431 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
2314431 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour
2314431 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive
2314431 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive
4536288 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
16108443 usd
CY2022Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2023Q4 us-gaap Goodwill
Goodwill
22324588 usd
CY2022Q4 OCTO Customer Deposits Liability Current
CustomerDepositsLiabilityCurrent
83504 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1831499 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
386781 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
280000 usd
CY2023Q4 OCTO Accrued Settlement Liability For Equity Holders Of Forever8
AccruedSettlementLiabilityForEquityHoldersOfForever8
206779 usd
CY2022Q4 OCTO Accrued Settlement Liability For Equity Holders Of Forever8
AccruedSettlementLiabilityForEquityHoldersOfForever8
469775 usd
CY2023Q4 OCTO Accrued Interest
AccruedInterest
3741155 usd
CY2022Q4 OCTO Accrued Interest
AccruedInterest
825872 usd
CY2023Q4 OCTO Accrued Rent
AccruedRent
1050000 usd
CY2022Q4 OCTO Accrued Rent
AccruedRent
525000 usd
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
357242 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
53586 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
7186675 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2624518 usd
CY2023Q4 OCTO Due To Affiliates
DueToAffiliates
6977193 usd
CY2022Q4 OCTO Due To Affiliates
DueToAffiliates
7226700 usd
CY2023Q4 OCTO Convertible Notes Payable Percentage
ConvertibleNotesPayablePercentage
0 pure
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7109078 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5697149 usd
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4532673 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4335611 usd
CY2023Q1 OCTO Loss On Issuance Of Warrants
LossOnIssuanceOfWarrants
197061 usd
CY2023Q1 OCTO Warrant Modification Expense
WarrantModificationExpense
664389 usd
CY2023Q1 OCTO Warrants Share Price
WarrantsSharePrice
0.12
CY2023Q2 OCTO Warrants Price Risk Option Strike Price
WarrantsPriceRiskOptionStrikePrice
2.01
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3387604 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3387604 usd
CY2022Q3 OCTO Percentage On Deposit Of Warrant Exercise Cash
PercentageOnDepositOfWarrantExerciseCash
0.50 pure
CY2022Q4 OCTO Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
14406 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
14133700 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-67719971 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-46850995 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-600443 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-768062 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68320414 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47619057 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
-8387 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
154298 usd
CY2023Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
270574 usd
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
54453 usd
CY2022Q4 OCTO Deferred Tax Assets Leases
DeferredTaxAssetsLeases
14808 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
140143 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8755550 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4419519 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9157880 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4628672 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
14406 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
82104 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
82104 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
82104 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
96510 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
82104 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
82104 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-172997 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-172997 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4415124 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4150207 usd
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-114084 usd
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
145932 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4529208 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
4004275 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-172997 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Minority Interest Income Expense
EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
-0.001 pure
CY2023 OCTO Effective Income Tax Rate Reconciliation Warrant Valuation
EffectiveIncomeTaxRateReconciliationWarrantValuation
-0.145 pure
CY2022 OCTO Effective Income Tax Rate Reconciliation Warrant Valuation
EffectiveIncomeTaxRateReconciliationWarrantValuation
-0.112 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.007 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.002 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
-0.003 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.062 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.087 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.004 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004 pure
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-172997 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8755550 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2544592
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
204404 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4800 shares
CY2022Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
8.00
CY2022Q3 OCTO Stock Issued During Period Shares Issued To Note Holders
StockIssuedDuringPeriodSharesIssuedToNoteHolders
30000 shares
CY2022Q3 OCTO Stock Issued During Period Value Issued To Note Holders
StockIssuedDuringPeriodValueIssuedToNoteHolders
1590000 usd
CY2023 us-gaap Payments For Rent
PaymentsForRent
849575 usd
CY2022 us-gaap Payments For Rent
PaymentsForRent
795959 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
609000 usd
CY2023Q4 us-gaap Assets
Assets
55411443 usd
CY2022Q4 us-gaap Assets
Assets
58600599 usd

Files In Submission

Name View Source Status
0001493152-24-012608-index-headers.html Edgar Link pending
0001493152-24-012608-index.html Edgar Link pending
0001493152-24-012608.txt Edgar Link pending
0001493152-24-012608-xbrl.zip Edgar Link pending
ex23-2.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
octo-20231231.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
octo-20231231_cal.xml Edgar Link unprocessable
octo-20231231_def.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
octo-20231231_pre.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
octo-20231231_lab.xml Edgar Link unprocessable